Jeffrey Quillen on Biotech Survival Strategies

The False Claims Act and The Life Sciences Industry: More to Come

Patent Portfolios in a Down Economy: Smart and Strategic Investments

What Bilski Means to Biotech: Barbara Fiacco on the Significance of This Patent Litigation